Search Within

Results 1 - 6 of 6
Clinical Profile of Eprosartan: A Different Angiotensin II Receptor Blocker

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 6,Issue: 4
Page: 253-257
Authors: P. J. Blankestijn and H. Rupp

Mas Receptor Agonists as Novel Antihypertensive Agents

Journal: Current Hypertension Reviews
Volume: 8,Issue: 1
Page: 24-34
Authors: Silvia Quintao Savergnini, Rodrigo Araujo Fraga-Silva, Anderson Jose Ferreira and Robson Augusto Souza dos Santos

A New Approach for Treatment of Hypertension: Modifying D1 Dopamine Receptor Function

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 4,Issue: 4
Page: 369-377
Authors: Chunyu Zeng, Robin A. Felder and Pedro A. Jose

Is Beta-Blocker Treatment Associated with a Decrease in the Risk of Cancer

Journal: Letters in Drug Design & Discovery
Volume: 3,Issue: 9
Page: 653-661
Authors: M. Algazi, G. Plu-Bureau, A. Flahault, M-G Dondon and M. G. Le

Effects of ACE-Inhibitors and Angiotensin Receptor Blockers on Inflammation

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 28
Page: 4385-4413
Authors: D. Di Raimondo, A. Tuttolomondo, C. Butta, S. Miceli, G. Licata and A. Pinto

Efficacy and Safety Assessment of Hypertension Management with Coveram (Perindopril/Amlodipine Fixed Combination) in Patients with Previous Angiotensin Receptor Blocker (ARB) Treatment: Arabian Gulf STRONG Study

Journal: Current Vascular Pharmacology
Volume: 14,Issue: 6
Page: 570-575
Authors: Mustafa Ahmed, Muath Alanbaei, Hassan El Tamimi, Yahya Al-Wahshi and Ibrahim Al-Zakwani

Results 1 - 6 of 6